dioxadrol
This page covers all dioxadrol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sigma non-opioid intracellular receptor 1.
Targets
Sigma non-opioid intracellular receptor 1
Phase 2 pipeline (1)
- DIOXADROL · Pain
DIOXADROL is a small molecule that works by interacting with a specific target, although the exact target and mechanism are unknown.
Patent intelligence
- dioxadrol patent landscape — aggregated cliff calendar, attackable patents, originator estates